Meet the Start-ups

Daniel Fischer | President & CEO | Tevard Biosciences

Daniel Fischer is co-founder and CEO of Tevard Biosciences, a company pioneering tRNA therapeutics to treat rare genetic diseases, including Dravet syndrome, a disease that affects his daughter Natasha. He brings extensive management and entrepreneurial expertise and has been a management consultant to Fortune 500 companies with several top-tier consultancies, including A.T. Kearney and Arthur D. Little.

Daniel worked at the Massachusetts Institute of Technology with industry and academic researchers in advancing the state-of-the-art in multiple disciplines, including AI/machine learning, biotechnology, and innovation management. Daniel was the founder and CEO of Intellimedix where he developed a platform for personalized medicine. In 2000 he co-founded and managed Comerxia, a company featured in TIME magazine as the leading solution for international ecommerce. Daniel is a 2022 Termeer Fellow.

Tevard Biosciences

Tevard is pioneering tRNA therapeutics to treat rare genetic disorders and addresses key shortcomings of traditional gene therapy such as, inability to deliver a large gene, overexpression, and specificity. Founded by renowned MIT Professor and Whitehead Institute Founding Member Harvey Lodish with entrepreneurs and executives Daniel Fischer and Warren Lammert, fathers of children with Dravet syndrome, a rare and severe type of genetic epilepsy.

Tevard’s lead program targets Dravet syndrome and other genetic epilepsies (DEEs). Other programs are in the field of cardiology and muscular dystrophy, the latter being partnered with Vertex Pharmaceuticals.